The race from chronic pancreatitis to pancreatic cancer

Journal of the Pancreas

Volumn 4, Issue 5, 2003, Pages 165-168

  Cavestro, Giulia Martina ^a   Comparato, Giuseppe ^a   Nouvenne, Antonio ^a   Sianesi, Mario ^a   Di Mario, Francesco ^a  

^a UNIVERSITY OF PARMA   (Italy)

Author keywords

Chemokines; Genetics inflammation mediators; Pancreatic neoplasms; Pancreatitis

Indexed keywords

CANCER GROWTH; CANCER INCIDENCE; CANCER RISK; CARCINOGENESIS; CAUSE OF DEATH; CHRONIC DISEASE; DISEASE ASSOCIATION; EATING HABIT; EDITORIAL; ENVIRONMENTAL FACTOR; ETHNIC DIFFERENCE; GENE INTERACTION; GENE MUTATION; GENETIC PREDISPOSITION; GENETIC STABILITY; HUMAN; PANCREAS CANCER; PANCREATITIS; SEX DIFFERENCE; ANIMAL; MORTALITY; PANCREAS TUMOR;

ANIMALS; CHRONIC DISEASE; HUMANS; PANCREATIC NEOPLASMS; PANCREATITIS;

EID: 3242668820     PISSN: 15908577     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (34)

1. Niederhuber JE, Brennan MF, Menck HR. The National Cancer Data Base report on pancreatic cancer. Cancer 1995; 76:1671-7. [PMID 8635074]
2. Greenlee RT, Hill-Harmon M, Murray T, Thun M. Cancer statistics, 2001. CA Cancer J Clin 2001; 51:15-36. [PMID 11577478]
3. Talamini G, Bassi C, Falconi M, Sartori N, Salvia R, Rigo L, et al. Alcohol and smoking as risk factors in chronic pancreatitis and pancreatic cancer. Dig Dis Sci 1999; 44:1303-11. [PMID 10489910]
4. DiMagno EP, Reber HA, Tempero MA. AGA technical review on the epidemiology, diagnosis, and treatment of pancreatic ductal adenocarcinoma. American Gastroenterological Association. Gastroenterology 1999; 117:1464-84. [PMID 10579989]
5. Michaud DS, Giovannucci E, Willett WC, Colditz GA, Stampfer MJ, Fuchs CS. Physical activity, obesity, height, and the risk of pancreatic cancer. JAMA 2001; 286:921-9. [PMID 11509056]
6. Potter JD. Pancreas cancer - we know about smoking, but do we know anything else? Am J Epidemiol 2002; 155:793-5. [PMID 11978581]
7. Bardeesy N, DePinho RA. Pancreatic cancer biology and genetics. Nat Rev Cancer 2002; 2:897-909. [PMID 12459728]
8. Lowenfels AB, Maisonneuve P, Cavallini G, Ammann RW, Lankisch PG, Andersen JR, Dimagno EP, Andren-Sandberg A, Domellof L. Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group. N Engl J Med 1993; 328:1433-7. [PMID 8479461]
9. Bansal P, Sonnenberg A. Pancreatitis is a risk factor for pancreatic cancer. Gastroenterology 1995;109:247-51. [PMID 7797022]
10. Fernandez E, La Vecchia C, Porta M, Negri E, d'Avanzo B, Boyle P. Pancreatitis and the risk of pancreatic cancer. Pancreas 1995; 11:185-9. [PMID 7479677]
11. Talamini G, Bassi C, Falconi M, Sartori N, Pasetto M, Salvia R, et al. Early detection of pancreatic cancer following the diagnosis of chronic pancreatitis. Digestion 1999; 60:554-61. [PMID 10545726]
12. Talamini G, Falconi M, Bassi C, Sartori N, Salvia R, Caldiron E, et al. Incidence of cancer in the course of chronic pancreatitis. Am J Gastroenterol 1999; 94:1253-60. [PMID 10235203]
13. Howes N, Neoptolemos JP. Risk of pancreatic ductal adenocarcinoma in chronic pancreatitis. Gut 2002; 51:765-6. [PMID 12427771]
14. Malka D, Hammel P, Maire F, Rufat P, Madeira I, Pessione F, et al. Risk of pancreatic adenocarcinoma in chronic pancreatitis. Gut 2002; 51:849-52. [PMID 12427788]
15. Maisonneuve P, Lowenfels AB. Chronic pancreatitis and pancreatic cancer. Dig Dis 2002; 20:32-7. [PMID 12145418]
16. Matsubayashi H, Watanabe H, Nishikura K, Ajioka Y, Kijima H, Saito T. Determination of pancreatic ductal carcinoma histogenesis by analysis of mucous quality and K-ras mutation. Cancer 1998; 82:651-60 [PMID 9477096]
17. Wilentz RE, Geradts J, Maynard R, Offerhaus GJ, Kang M, Goggins M, Yeo CJ, Kern SE, Hruban RH. Inactivation of the p16 (INK4A) tumor-suppressor gene in pancreatic duct lesions: loss of intranuclear expression. Cancer Res 1998; 58:4740-4. [PMID 9788631]
18. Berger DH, Chang H, Wood M, Huang L, Heath CW, Lehman T, Ruggeri BA. Mutational activation of K-ras in nonneoplastic exocrine pancreatic lesions in relation to cigarette smoking status. Cancer 1999; 85:326-32. [PMID 10023699]
19. Luttges J, Schlehe B, Menke MA, Vogel I, Henne-Bruns D, Kloppel G. The K-ras mutation pattern in pancreatic ductal adenocarcinoma usually is identical to that in associated normal, hyperplastic, and metaplastic ductal epithelium. Cancer 1999; 85:1703-10. [PMID 10223563]
20. Wilentz RE, Iacobuzio-Donahue CA, Argani P, McCarthy DM, Parsons JL, Yeo CJ, et al. Loss of expression of DPC4 in pancreatic intraepithelial neoplasia: evidence that DPC4 inactivation occurs late in neoplastic progression. Cancer Res 2000; 60:2002-6. [PMID 10766191]
21. Gerdes B, Ramaswamy A, Kersting M, Ernst M, Lang S, Schuermann M, et al. p16 (INK4a) alterations in chronic pancreatitis-indicator for high-risk lesions for pancreatic cancer. Surgery 2001; 129:490-7. [PMID 11283541]
22. Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet 2001; 357:539-45. [PMID 11229684]
23. Farrow B, Evers BM. Inflammation and the development of pancreatic cancer. Surg Oncol 2002;10:153-69. [PMID 12020670]
24. Liotta LA, Kohn EC. The microenvironment of the tumour-host interface. Nature 2001; 411:375-9. [PMID 11357145]
25. Friess H, Guo XZ, Nan BC, Kleeff O, Buchler MW. Growth factors and cytokines in pancreatic carcinogenesis. Ann N Y Acad Sci 1999; 880:110-21. [PMID 10415856]
26. Basso D, Plebani M. Cytokines and exocrine pancreatic cancer: is there a link? JOP. J Pancreas (Online) 2000; 1:19-23. [PMID 11852286]
27. McDade TP, Perugini RA, Vittimberga FJ, Carrigan RC, Callery MP. Salicylates inhibit NFkappaB activation and enhance TNF-alpha-induced apoptosis in human pancreatic cancer cells. J Surg Res 1999; 83:56-61. [PMID 10210643]
28. Tak PP, Firestein GS. NF-kappaB: a key role in inflammatory diseases. J Clin Invest 2001; 107:7-11. [PMID 11134171]
29. Williams C, Shattuck-Brandt RL, DuBois RN. The role of COX-2 in intestinal cancer. Ann N Y Acad Sci 1999; 889:72-83. [PMID 10668484]
30. Kokawa A, Kondo H, Gotoda T, Ono H, Saito D, Nakadaira S, et al. Increased expression of cyclooxygenase-2 in human pancreatic neoplasms and potential for chemoprevention by cyclooxygenase inhibitors. Cancer 2001; 91:333-8. [PMID 11180079]
31. Tucker ON, Dannenberg AJ, Yang EK, Zhang F, Teng L, Daly JM, et al. Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer. Cancer Res 1999; 59:987-90. [PMID 10070951]
32. Okami J, Yamamoto H, Fujiwara Y, Tsujie M, Kondo M, Noura S, et al. Overexpression of cyclooxygenase-2 in carcinoma of the pancreas. Clin Cancer Res 1999; 5:2018-24. [PMID 10473081]
33. Weitzman SA, Gordon LI. Inflammation and cancer: role of phagocyte-generated oxidants in carcinogenesis. Blood 1990; 76:655-63. [PMID 2200535]
34. Cerutti PA. Oxy-radicals and cancer. Lancet 1994; 344:862-3. [PMID 7916406]